Pharma & Biotech

While Curis shares closed flat at $1.67 in recent trading, market experts continue to express confidence in the biotechnology firm's...

Jazz Pharmaceuticals has achieved two significant regulatory milestones for its oncology therapeutic, Modeyso. The company obtained both an accelerated approval...

Biotech firm Akari Therapeutics finds itself navigating a severe financial crisis, marked by the abrupt departure of its chief financial...

Celularity Inc. finds itself navigating a critical period as it confronts potential delisting from the Nasdaq exchange. The biotechnology company...

The biotechnology firm Atara Biotherapeutics stands at a pivotal juncture. Following significant regulatory progress and unexpectedly strong quarterly earnings, the...

Eli Lilly stands poised to revolutionize obesity treatment with its experimental oral medication Orforglipron, following outstanding Phase 3 clinical trial...

Investors in Rockwell Medical experienced significant volatility as the dialysis product manufacturer's stock declined 5% on Friday. This pullback arrived...

A remarkable convergence of fundamental strength and technical indicators has propelled InfuSystem Holdings Inc. to impressive gains, with its equity...

Veeva Systems delivered a powerful quarterly performance that surpassed expectations, simultaneously announcing a landmark strategic alliance with biotechnology leader Amgen....

X4 Pharmaceuticals is undergoing a profound corporate transformation, marked by a complete overhaul of its executive leadership and the successful...